Proto Labs, Inc. (NYSE:PRLB) Given Consensus Rating of “Buy” by Brokerages

Proto Labs, Inc. (NYSE:PRLB) has been given a consensus rating of “Buy” by the five research firms that are currently covering the company, MarketBeat Ratings reports. Four investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $53.3333.

Several equities research analysts have commented on PRLB shares. Wall Street Zen lowered shares of Proto Labs from a “strong-buy” rating to a “buy” rating in a research note on Monday, June 15th. Zacks Research upgraded shares of Proto Labs from a “hold” rating to a “strong-buy” rating in a research note on Monday, May 11th. Finally, Weiss Ratings upgraded shares of Proto Labs from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Thursday, June 11th.

Proto Labs Stock Down 0.1%

Shares of NYSE PRLB opened at $80.94 on Tuesday. The firm’s 50-day moving average price is $70.55 and its two-hundred day moving average price is $61.42. Proto Labs has a 52-week low of $37.91 and a 52-week high of $83.15. The stock has a market capitalization of $1.93 billion, a P/E ratio of 76.36 and a beta of 1.39.

Proto Labs (NYSE:PRLB) last issued its earnings results on Friday, May 1st. The industrial products company reported $0.54 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.40 by $0.14. Proto Labs had a net margin of 4.71% and a return on equity of 4.15%. The firm had revenue of $139.34 million for the quarter, compared to analysts’ expectations of $135.31 million. During the same quarter last year, the company posted $0.33 earnings per share. Proto Labs’s revenue was up 10.4% on a year-over-year basis. Proto Labs has set its Q2 2026 guidance at 0.500-0.580 EPS. As a group, equities research analysts expect that Proto Labs will post 1.37 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Sven Wehrwein sold 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $77.28, for a total transaction of $154,560.00. Following the transaction, the director owned 32,505 shares in the company, valued at $2,511,986.40. This trade represents a 5.80% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Michael R. Kenison sold 16,030 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $69.49, for a total transaction of $1,113,924.70. Following the transaction, the insider owned 18,683 shares in the company, valued at $1,298,281.67. This represents a 46.18% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 25,663 shares of company stock worth $1,804,727 in the last quarter. Company insiders own 1.30% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Pacer Advisors Inc. increased its stake in shares of Proto Labs by 74.2% during the first quarter. Pacer Advisors Inc. now owns 5,653 shares of the industrial products company’s stock valued at $322,000 after acquiring an additional 2,407 shares during the period. Bank of America Corp DE increased its stake in shares of Proto Labs by 38.3% during the first quarter. Bank of America Corp DE now owns 129,113 shares of the industrial products company’s stock valued at $7,362,000 after acquiring an additional 35,784 shares during the period. Edgestream Partners L.P. bought a new stake in Proto Labs during the first quarter worth approximately $1,084,000. Amundi boosted its holdings in Proto Labs by 16.9% during the first quarter. Amundi now owns 14,082 shares of the industrial products company’s stock worth $803,000 after buying an additional 2,031 shares in the last quarter. Finally, Quantinno Capital Management LP boosted its holdings in Proto Labs by 98.9% during the first quarter. Quantinno Capital Management LP now owns 27,716 shares of the industrial products company’s stock worth $1,580,000 after buying an additional 13,781 shares in the last quarter. Institutional investors and hedge funds own 84.54% of the company’s stock.

Proto Labs Company Profile

Proto Labs, Inc is a digital manufacturing company that offers on-demand production services for custom parts and prototypes. Utilizing technologies such as 3D printing (additive manufacturing), CNC machining and injection molding, the company transforms digital CAD designs into functional parts on accelerated timelines. Its platform-driven process combines automated quoting, rapid tool generation and manufacturing execution to serve product developers, engineers and small- to medium-sized production runs.

Founded in 1999 by Larry Lukis, Proto Labs has championed the application of digital workflows to traditional manufacturing methods.